Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them: Addressing Cta Delays Comprehensively
    The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them: Addressing Cta Delays Comprehensively
    The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them: Addressing Cta Delays Comprehensively
    Ebook86 pages1 hour

    The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them: Addressing Cta Delays Comprehensively

    By Débora S. Araujo and T.J. Sharpe

    ()

    Read preview

    About this ebook

    Fictional superheroes are often charged with the task of saving the world from villains such as the Joker, Lex Luthor, Doctor Doom, and the Green Goblin. But superheroes cannot be effective if they only take out one of their villains and let the others roam free. In the same way, the pharmaceutical industry cannot effectively tackle the issue of delays in the execution of clinical trial agreements (CTAs) that leave patients lives hanging in the balance by only addressing one or two of the villains contributing to this broad challenge.

    Dbora Araujo relies on seasoned experience in the pharmaceutical industry that includes consulting for Fortune 500 companies and driving practical change regarding the business aspects of clinical trials to share a comprehensive exploration of the four villains who contribute to CTA negotiation delays and provide practical ways to address each of them. While encouraging positive change that patients desperately need, Araujo examines the negative impacts of ineffective site-budget negotiations, poor outsourced negotiations, a lack of industry adoption and innovation, and other issues affecting CTA negotiations. Included are several checklists, a common language evaluation and reconciliation initiative, and general CTA country requirements.

    In this comprehensive study, a pharmaceutical professional creatively examines how to address the four villains that cause frustrating delays in the execution of clinical trial agreements.

    LanguageEnglish
    PublisherWestBow Press
    Release dateApr 9, 2018
    ISBN9781973622680
    The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them: Addressing Cta Delays Comprehensively
    Author

    Débora S. Araujo

    Dbora S. Araujo has over a decade of experience in the pharmaceutical industry, working and consulting for Fortune 500 companies. During her time in this industry, her special focus has been on the business aspects of clinical trials. She has utilized her expertise and knowledge to drive practical change in this industry via thought leadership material, conference presentations, and other engagements. Most recently, Dboras passion for driving practical change along with her forward-thinking bent led her to launch ClinBiz (www.clinbiz.com), an online platform with a dedicated YouTube channel, podcast, blog and much more where clinical research professionals can stay connected and updated on the latest topics, trends and technologies related to the business aspects of clinical trials. When she is not contributing in the business world, Dbora loves to spend time relaxing with her husband, Altair, and her two boys, Matthew and Timothy, in the great garden state of New Jersey.

    Related to The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      At $2.1 Million, Newly Approved Novartis Gene Therapy Will Be World’s Most Expensive Drug

      May 24, 2019

      The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most…

      4 min read

    • Article

      Restricting Drug Reps May Shift Doctors to Generics

      May 3, 2017

      A new study suggests that restricting how pharmaceutical sales representatives can market drugs to physicians changes which medications doctors prescribe to their patients. A team of researchers examined restrictions at 19 academic medical centers (A

      2 min read

    • Article

      Expanding Precision Medicine

      Jul 30, 2020

      Expanding Precision Medicine
      9 min read

    • Article

      Match Matters: Here’s Some Advice on How to Interview for Your Residency

      Nov 24, 2017

      Where we match can have a profound impact on our lives, and on the communities where we learn. Here are some tips on how to find that best fit.

      5 min read

    • Article

      Stay Or Leave?

      Aug 28, 2019

      Stay Or Leave?
      4 min read

    • Article

      Q&A: Philip Moeller

      Dec 18, 2020

      Q&A: Philip Moeller
      3 min read

    • Article

      We Are Running in 'Degraded Mode'

      Nov 23, 2021

      Welcome to Galaxy Brain -- a newsletter from Charlie Warzel about technology and culture and big ideas. You can read what this is all about here. If you like what you see, consider forwarding it to a friend or two. We're still figuring things out in

      8 min read

    • Article

      Editor's Note

      Aug 25, 2022

      Editor's Note
      2 min read

    • Article

      Trust Is A Contact Sport

      Jun 6, 2018

      Consistency, responsiveness and transparency are often cited as the key ingredients to building trust, as these are able to anticipate specific feeling towards specific experiences. By standardising their practises, brands are able to ensure expectat

      3 min read

    • Article

      Q & A

      Mar 22, 2024

      Q _ Were you ultimately successful in your quest to conceive? A _ I am currently pregnant, due in mid-May. I can’t wait to meet my son! Is there anything you would have done differently along the way? There is a donor I mention in the book who I wo

      4 min read

    • Article

      Valerie Bauman

      Mar 22, 2024

      Q _ Were you ultimately successful in your quest to conceive? A _ I am currently pregnant, due in mid-May. I can’t wait to meet my son! Is there anything you would have done differently along the way? There is a donor I mention in the book who I wo

      4 min read

    • Article

      How To Talk About Climate Change

      Aug 11, 2022

      If you’ve ever thought you’re not a good speaker or writer, you’re among friends: this is the top barrier to action identified by the 24 per cent of Australians who are most alarmed about climate change, according to research by government body Clima

      2 min read

    • Article

      An Invitation To Reconcile

      May 20, 2021

      An Invitation To Reconcile
      3 min read

    • Article

      The Human Factor

      Mar 31, 2019

      The Human Factor
      10 min read

    • Article

      Saying No Takes Practice

      Nov 25, 2017

      Saying No Takes Practice
      2 min read

    • Article

      A Guide For Care Givers

      Feb 6, 2020

      A Guide For Care Givers
      3 min read

    • Article

      Human Touch

      Sep 12, 2021

      Human Touch
      2 min read

    • Article

      Human Touch

      Sep 12, 2021

      Human Touch
      2 min read

    • Article

      Should You Tell Everyone They’re Honest?

      Jun 28, 2018

      Here is the predicament that most of us seem to be in. We are not virtuous people. We simply do not have characters that are good enough to qualify as honest, compassionate, wise, courageous, and the like. We are not vicious people either—dishonest,

      10 min read

    Related categories

    Reviews for The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      The Four Villains of Clinical Trial Agreement Delays and How to Defeat Them - Débora S. Araujo

      Qabook_preview_excerpt.htmlXn0C!SFO IXpvwS]ժdE>!l'd$%:^c]8s&e/?㓗~.|H͂~GY{y^άU6@š#uUCR~Rm*_FoTAT) JUlvՐvqA)',)xǿCۉ2]eROcCK*tq8޸N;Y֧`hQI&9RhLO"; >&,K8q>v>]QQSO,,q&SZ0kC}{4n#ޚ͸}&iVB6m0k߼7OngˋVoو7x]\''/ϟW/'ϏRIq1r:uatGi"yPaƭ*KڸC0xRmWXUe+&0cdz5'B^HEon<RgWG'~ Z0Xee>~&vŚDw}6 󑺫uhiYrT-r)~~RWnQ%d.dׂe8K_T-!$%%P'3p^ ]r%w,54F⫾M+^Y[u ;・oCbXnֱ`>#6ܾ=5geQl JG ƃ-MuZ3v]?+ݶ 4LzPKLZpWg CY@(=V,0Z>9\h<yykj+g]>ӵ#j"oU@W3rI=Jх86KIl @yhuf [{1jujaVQFG̤ hC 'g tAX+lԷHOx 4 ]XQh`k^QY&lͷ,rX_R>B`, WEA@}i.!Dv]m#$seEj 1KޫHx ilqd Ks8D߰ $Jq' l_=m&.gD4Hv1-/TɦJ%l10!RבC+Cid/|.^:?3SQ*:(AO`.L4ȢBxt~1-^Ff5b͛М q&-%RBb2]3Vk$ŧA,CLCа'7 q7!nsX$Y[1!yCe$.A4|79K`r˖*":C&d>17HqY0A2 l$[J8ܶ]Ӏq-!P"-aU\8,QJ Bӗd@IRsQ2F?cN=i̓ \8):!r)FQ 8sta%%]Vqgn;ސZ'Fv5r$M:x]Sgt+wP'BpO8 KK\m1끵gvBnVq()A@mf A/}# O,i/Zcdor,ae)78 G9=Y!?ލp2`c1~hMZ?,#O+\x Kga'f4G3X`)cG_]l  A#Z]4OC٦GߕǭTa` TCE ̡!kV]$8 8jщ˫>vP'_Odžm7C k,aVܧ{=z%[!]14>J!VDZDbǭfhN}bKD6(:c>q)Vڀbsf DA92 t&CLz25i,O"HAHzQp/?qmE FZ.EHgةq$><Vc}":?+"[#3fIg`vY+e|Pk|vNb"OvM818*p <}Ed\BFzɰikQ/R7xOT#leD]LKœ,Uܱ4yJա7hR4j7 X:)&͢X]y3[}%{KWX6fbV> q[4 <
      Enjoying the preview?
      Page 1 of 1